To evaluate our findings on NEDD9-driven MIN/DCIS increase in the human model, we overexpressed NEDD9 in human mammary epithelial cells—MCF10A—alone, or in combination with HER2 or empty vector controls (Figure 7A). Here, NEDD9 is linked to ductal breast carcinoma in situ.